Powered Prosthetics for Knee Amputations
Trial Summary
What is the purpose of this trial?
The goal of this study is to understand how providing power at the knee or ankle individually, or providing power at both the knee and ankle, impacts ambulation for K2 level transfemoral amputees. Aim 1: measure functional performance of K2 level ambulators when using a commercially available passive microprocessor knee prosthesis (Ottobock Cleg/Ottobock foot) or a powered knee and ankle prosthesis (SRALab Hybrid Knee and SRAlab Polycentric Powered Ankle. Aim 2: Participants will be evaluated on the contribution of adding power at the knee only or the ankle only. Aim 3: The investigators will evaluate the functional performance after intensive clinical gait training on the powered knee and ankle prosthesis (SRALab Hybrid Knee and SRALab Polycentric Powered Ankle). Our hypothesis is that providing powered componentry will improve function and that intensive training will magnify those improvements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team or your doctor for guidance.
What data supports the effectiveness of the treatment SRALab Hybrid Knee and SRALab Polycentric Powered Ankle for knee amputations?
Research on similar powered prosthetic knees and ankles shows that they can help people with above-knee amputations walk more naturally and efficiently, even on stairs. Studies also suggest that these devices can improve walking speed and reduce the risk of falls, enhancing overall mobility and quality of life.12345
Is the powered prosthetic knee and ankle safe for humans?
The research indicates that powered prosthetic knees and ankles have been used safely in individuals with above-knee amputations, allowing them to walk and climb stairs with natural movements. While specific safety data is limited, the studies suggest these devices can be configured effectively for different walking modes, potentially making them a viable option for improving mobility.46789
How does the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle treatment differ from other treatments for knee amputations?
The SRALab Hybrid Knee and SRALab Polycentric Powered Ankle treatment is unique because it combines powered components that replicate natural leg movements, enabling more natural walking and stair climbing for individuals with knee amputations. Unlike passive prostheses, these powered devices can generate positive knee power and restore natural ankle push-off, improving functional mobility and quality of life.1241011
Eligibility Criteria
This trial is for K2-level transfemoral amputees, meaning individuals who have had an above-knee amputation and can walk with a cane or crutches. The study aims to understand the impact of powered prosthetic knees and ankles on their walking ability.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline data collection with Ottobock Cleg 4/Ottobock foot or clinically prescribed microprocessor knee unit/foot
Condition A: CLeg + Polycentric Ankle
Participants are fit with the CLeg + Polycentric Ankle and undergo device tuning and functional outcome assessments
Condition B: SRALab Hybrid Knee + Passive Ankle
Participants switch to SRALab Hybrid Knee + Passive Ankle and repeat the protocol for device tuning and assessments
Intensive Training
Participants receive intensive clinical training with the SRALab Hybrid Knee + Polycentric Ankle
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- SRALab Hybrid Knee and SRALab Polycentric Powered Ankle
SRALab Hybrid Knee and SRALab Polycentric Powered Ankle is already approved in United States for the following indications:
- Transfemoral amputation for K2 level ambulators
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor